Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR). Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Maslak, Peter George
  • Dao, Tao
  • Bernal, Yvette
  • Chanel, Suzanne M
  • Zhang, Rong
  • Frattini, Mark G
  • Rosenblat, Todd L
  • Jurcic, Joseph G
  • Rampal, Raajit
  • Park, Jae Hong
  • Douer, Dan
  • Katz, Laura
  • Gutierrez, Andres A
  • Tallman, Martin S
  • Scheinberg, David A

publication date

  • May 20, 2016